Curing metastatic cancer: lessons from testicular germ-cell tumours.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12835671.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Most metastatic cancers are fatal. More than 80% of patients with metastatic testicular germ-cell tumours (TGCTs), however, can be cured using cisplatin-based combination chemotherapy. Why are TGCTs more sensitive to chemotherapeutics than most other tumour types? Answers to this question could lead to new treatments for metastatic cancers.
Medical subject headings
- Neoplasm Metastasis
- Neoplasms, Germ Cell and Embryonal
- Testicular Neoplasms